Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
India
/
Pharmaceuticals & Biotech
/
Jeena Sikho Lifecare
JSLL
Jeena Sikho Lifecare
Infrastructure Expansion Will Serve India's Aging Wellness Market
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 1 Analyst
Published
10 Aug 25
Updated
21 Aug 25
2
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
₹900.00
20.0% undervalued
intrinsic discount
21 Aug
₹720.10
Loading
1Y
159.6%
7D
9.1%
Author's Valuation
₹900.0
20.0% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
₹900.0
20.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
16b
2019
2021
2023
2025
2027
2028
Revenue ₹16.3b
Earnings ₹4.4b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
37.10%
Pharma revenue growth rate
0.56%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.73%
Calculation
₹4.42b
Earnings '28
x
36.15x
PE Ratio '28
=
₹159.87b
Market Cap '28
₹159.87b
Market Cap '28
/
123.92m
No. shares '28
=
₹1.29k
Share Price '28
₹1.29k
Share Price '28
Discounted to 2025 @ 12.73% p.a.
=
₹900.58
Fair Value '25